Pier Capital’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
AAM
WCMNY
PWAM
PCM
Pier Capital's AMED Position: Q4 2023 in Review
Pier Capital sold out of Amedisys (AMED) in Q4 2023, closing a stake of 97,083 shares — an estimated $9.07M sold.
Pier Capital first reported a position in AMED in Q1 2016 and held it in 14 quarters. The position peaked at $11.3M in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q4 2023.
- Pier Capital reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
- Pier Capital sold 97,083 Amedisys shares in Q4 2023, an estimated $9.07M.
- Pier Capital first reported a position in Amedisys in Q1 2016 and held it in 14 quarters.
- Pier Capital's Amedisys position peaked at $11.3M in Q4 2020.
- 288 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.
Based on Pier Capital's 13F filing for Q4 2023, filed 15 Feb 2024.